Nicoderm Patch, Extended Release
Product Images NDC 0135-0195

3 FDA label images from Haleon Us Holdings Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicoderm (NDC 0135-0195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Haleon Us Holdings Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200697 Nicoderm Cq 21mg Clear Patch 14 Count.jpg (200697 Nicoderm Cq 21mg Clear Patch 14 Count)

200697 Nicoderm Cq 21mg Clear Patch 14 Count.jpg (200697 Nicoderm Cq 21mg Clear Patch 14 Count)
NicoDerm CQ 21 mg/24h nicotine transdermal patch packaging. The front label highlights it as a clear, extended-release patch delivering nicotine over 24 hours with SmartControl technology. It is Step 1 of the treatment for smokers of more than 10 cigarettes a day, contains 14 clear patches in a 2-week kit, and is labeled by Haleon US Holdings LLC.*
FDA Label Image

Pa201227 Nicoderm Cq 14 mg Clear Patch 14 Count (Fc1e1428 9c5d 4b9d Bb1c D5594162aeb0 00)

Pa201227 Nicoderm Cq 14 mg Clear Patch 14 Count (Fc1e1428 9c5d 4b9d Bb1c D5594162aeb0 00)
The packaging label for NICODERM CQ 14 mg/24h Nicotine Transdermal System patch. The label shows the product as a clear extended-release patch designed for smoking cessation, delivering nicotine over 24 hours. It is a step 2 treatment for smokers using 10 or fewer cigarettes per day. The package contains 14 clear patches for a 2-week kit and is labeled by Haleon US Holdings LLC.*
FDA Label Image

201228_ Nicoderm Cq 21mg Clear Patch 14 Count.jpg (201228 Nicoderm Cq 21mg Clear Patch 14 Count)

201228_ Nicoderm Cq 21mg Clear Patch 14 Count.jpg (201228  Nicoderm Cq 21mg Clear Patch 14 Count)
NICODERM CQ 7 mg/24h nicotine transdermal patch packaging shows a clear, extended-release patch designed for smoking cessation. The label highlights the patch is step 3 in a treatment program and includes 14 clear patches intended as a 2-week kit. The labeler is Haleon US Holdings LLC, and the patch uses smart control technology for nicotine delivery over 24 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.